Seems something up with these two and Pfizer is already 10% holder.$153 million or $9 a share royalties to Psivida, $2.40 in cash of Psivida after approval, 0 debt, and big royalty stream form Alimera from Iluvien to tune of $15 million in eps 2011 means at current sp of under $6 makes it a terrific value down here and fair value should be north of $12-13 a share or a double now.
Add to My Watchlist
What is My Watchlist?